Disetronic doubles US sales operations:
This article was originally published in Clinica
Swiss diabetes management company Disetronic is to double its US fields sales and service organisation, in St Paul, Minnesota, in order to allow it to expand clinical support for physicians and to begin calling on primary care, diabetes educators and internal medicine physicians. "Today more and more physicians are prescribing insulin pumps and they need clinical support to back them up," said Thomas Meyer, CEO of Burgdorf-based Disetronic. The company says it is the second largest insulin pump company in the US.
You may also be interested in...
Less-invasive technologies to treat benign prostatic hyperplasia are fast becoming viable alternatives to medication and surgery. Here's what one researcher in the area, Steven Raman, had to say about the new options.
Novartis’s first digital innovation hub in Asia is launched in India, where the Swiss company hopes to ally with partners to deliver digital solutions for patients at scale.
Senate Finance Committee’s approach to penalize companies for raising WAC list prices is not a ‘price control,’ but a reasonable approach to change the incentives that distort pricing in the supply chain, US HHS Secretary Alex Azar says.